Blaise Genton, MD-PhD

Trials

Studies that name Blaise Genton, MD-PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:33 UTC. Open this list on ClinicalTrials.gov

• Ph2/Ph3
  NCT04385264 · #StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19

  Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland · withdrawn · COVID-19 · principal investigator
• Ph1/Ph2
  NCT02289027 · A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

  Centre Hospitalier Universitaire Vaudois · completed · Ebola Vaccines
• Ph1/Ph2
  NCT01031524 · Trial to Assess the Efficacy of Malaria Vaccine PfCS 102

  Swiss Tropical & Public Health Institute · completed · Plasmodium Falciparum Malaria
• Ph1
  NCT00513669 · Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

  Swiss Tropical & Public Health Institute · completed · Falciparum Malaria
• Ph1
  NCT00400101 · Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides

  Swiss Tropical & Public Health Institute · terminated · Falciparum Malaria
• Ph2
  NCT00322907 · Cotrifazid Safety and Efficacy Against Malaria

  Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland · terminated · Clinical Malaria

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.